数字糖尿病管理
Search documents
又一并购完成!打造“医院到家”糖尿病管理平台
思宇MedTech· 2025-09-24 09:09
Core Insights - Glooko, Inc. has acquired Monarch Medical Technologies to enhance its diabetes management platform, expanding from outpatient and home care to inpatient glucose control, creating a comprehensive "hospital-to-home" diabetes management solution [1][23] Acquisition Details - Monarch will operate independently in the short term, ensuring that EndoTool users are not affected, with a long-term goal of integrating EndoTool's algorithms into Glooko's existing platform [2][3] Product Highlights of Monarch/EndoTool - EndoTool is a recognized advanced insulin dosing decision support system, approved by the FDA, utilizing model predictive control (MPC) algorithms to recommend insulin doses based on various patient factors [7][12] - The system has been deployed in over 300 hospitals across the U.S., serving 8 out of the top 10 healthcare systems, and targets 30%-40% of hospitalized patients requiring insulin treatment, approximately 17 million patients annually [5][9] Clinical Impact - EndoTool significantly reduces the risk of hypoglycemia by over 50% and accelerates the achievement of target blood glucose levels, with a low hypoglycemia occurrence rate of approximately 0.01% [14] - The system integrates seamlessly with major electronic health record (EHR) systems, providing real-time dosing recommendations and ensuring continuous operation in high-risk environments [12][20] Glooko's Product Ecosystem - Glooko's mobile app serves as a comprehensive diabetes management tool, allowing users to track their blood glucose levels and treatment progress, while the web app aids healthcare providers in monitoring and managing patient care [16][18] - The platform supports over 200 diabetes-related devices, enabling data synchronization and closed-loop management across various care settings [20] Future Outlook - With the integration of EndoTool, Glooko aims to serve over 5 million users by 2026, establishing a unique position in the global digital diabetes ecosystem and enhancing safety and efficiency in glucose management for hospitals and patients [23]